Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Structural Heart Disease
What is the best approach to asymptomatic severe primary tricuspid regurgitation when imaging begins to show RV enlargement?
Related Questions
In a patient with suspected prosthetic valve endocarditis, how long after prosthetic valve implantation is an FDG PET reasonable to rule out infection?
How should one approach management of a patient with asymptomatic severe primary (prolapse) TR and normal RV function (EF and strain) but with RA/RV enlargement?
Which anticoagulant (DOAC or Warfarin) would you recommend in the case of a 70-year-old male with persistent atrial fibrillation and history of rheumatic mitral stenosis now status post bioprosthetic MVR?
In patients with contraindications to TEE and poor windows for TTE, what is the next best test to look for PFO?
How do you decide between opting for semi-elective outpatient versus inpatient TAVR for patients with severe critical AS?
Would you recommend starting an SGLT-2 inhibitors in patients with non-severe aortic stenosis based on recent evidence suggesting it may slow progression of disease?
Would it be reasonable to consider combined BAV plus staged PCI in a patient presenting with ACS and new LV systolic dysfunction, moderate aortic stenosis, and complex bifurcating left main disease and RCA CTO?
Is there any role for routine CT TAVR a few months after TAVR to look for HALT?
In a patient with severe TR, when is the best time to start thinking about T-TEER?
What would be your approach for the management of asymptomatic, severe AS with a peak velocity of 5 m/s in an otherwise physically active patient in their mid-90s without significant co-morbidities?
